Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients Via Analysis of Immunoinflammation-related Protein Complexes in Blood

The relationship between immune inflammation-related protein complexes in blood of triple negative breast cancer patients and recurrence or metastasis of breast cancer will be studied.

200 patients with triple negative breast cancer will be followed up. Peripheral venous blood was collected every 3 to 6 months. Change regularity of breast cancer-specific immune inflammation-related protein complexes in blood at different follow-up time points will be studied. The relationship between disease-specific protein complexes and pathological state of patients will be analyzed.

Inclusion Criteria:

• Female
• Postoperative pathology confirmed invasive breast cancer after surgery for breast lump
• Breast cancer-related chemotherapy and radiotherapy completed
• triple negative breast cancer patients
• age ≤ 60 years old

Exclusion Criteria:

• Male
• Aged above 60
• Breast Carcinoma in situ
• Women in pregnancy or breastfeeding
• Suffering from other malignant tumors
• Non-compliant patient